▶ 調査レポート

世界の水痘(水疱瘡)ワクチン市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Chickenpox (Varicella) Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の水痘(水疱瘡)ワクチン市場 2021:企業別、地域別、種類・用途別 / Global Chickenpox (Varicella) Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X03666資料のイメージです。• レポートコード:GIR-105X03666
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、87ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、水痘(水疱瘡)ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。水痘(水疱瘡)ワクチンの種類別市場規模(一価ワクチン、混合ワクチン)、用途別市場規模(子供用注射、大人用注射)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・水痘(水疱瘡)ワクチンの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Merck & Co.、Sanofi Pasteur、GSK、Shanghai Institute、BCHT、Changsheng、Keygen、Green Cross、Biken
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:一価ワクチン、混合ワクチン
・用途別分析2016年-2026年:子供用注射、大人用注射
・水痘(水疱瘡)ワクチンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・水痘(水疱瘡)ワクチンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・水痘(水疱瘡)ワクチンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・水痘(水疱瘡)ワクチンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・水痘(水疱瘡)ワクチンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Chickenpox (Varicella) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Chickenpox (Varicella) Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Chickenpox (Varicella) Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Chickenpox (Varicella) Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Monovalent Vaccine
Combination Vaccine

Market segment by Application can be divided into
Kids Injection
Adults Injection

The key market players for global Chickenpox (Varicella) Vaccine market are listed below:
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Chickenpox (Varicella) Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chickenpox (Varicella) Vaccine, with price, sales, revenue and global market share of Chickenpox (Varicella) Vaccine from 2019 to 2021.
Chapter 3, the Chickenpox (Varicella) Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chickenpox (Varicella) Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Chickenpox (Varicella) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Chickenpox (Varicella) Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Chickenpox (Varicella) Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chickenpox (Varicella) Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Chickenpox (Varicella) Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Chickenpox (Varicella) Vaccine Market Size & Forecast
1.4.1 Global Chickenpox (Varicella) Vaccine Sales in Value (2016-2026))
1.4.2 Global Chickenpox (Varicella) Vaccine Sales in Volume (2016-2026)
1.4.3 Global Chickenpox (Varicella) Vaccine Price by Type (2016-2026) & (USD/dose)
1.5 Global Chickenpox (Varicella) Vaccine Production Capacity Analysis
1.5.1 Global Chickenpox (Varicella) Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Chickenpox (Varicella) Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chickenpox (Varicella) Vaccine Market Drivers
1.6.2 Chickenpox (Varicella) Vaccine Market Restraints
1.6.3 Chickenpox (Varicella) Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Product and Services
2.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product and Services
2.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Chickenpox (Varicella) Vaccine Product and Services
2.3.4 GSK Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Shanghai Institute
2.4.1 Shanghai Institute Details
2.4.2 Shanghai Institute Major Business
2.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Product and Services
2.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 BCHT
2.5.1 BCHT Details
2.5.2 BCHT Major Business
2.5.3 BCHT Chickenpox (Varicella) Vaccine Product and Services
2.5.4 BCHT Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Changsheng
2.6.1 Changsheng Details
2.6.2 Changsheng Major Business
2.6.3 Changsheng Chickenpox (Varicella) Vaccine Product and Services
2.6.4 Changsheng Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Keygen
2.7.1 Keygen Details
2.7.2 Keygen Major Business
2.7.3 Keygen Chickenpox (Varicella) Vaccine Product and Services
2.7.4 Keygen Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Green Cross
2.8.1 Green Cross Details
2.8.2 Green Cross Major Business
2.8.3 Green Cross Chickenpox (Varicella) Vaccine Product and Services
2.8.4 Green Cross Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Biken
2.9.1 Biken Details
2.9.2 Biken Major Business
2.9.3 Biken Chickenpox (Varicella) Vaccine Product and Services
2.9.4 Biken Chickenpox (Varicella) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Chickenpox (Varicella) Vaccine Sales by Manufacturer
3.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chickenpox (Varicella) Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Chickenpox (Varicella) Vaccine Manufacturer Market Share
3.4.2 Top 6 Chickenpox (Varicella) Vaccine Manufacturer Market Share
3.5 Global Chickenpox (Varicella) Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chickenpox (Varicella) Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chickenpox (Varicella) Vaccine Market Size by Region
4.1.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Chickenpox (Varicella) Vaccine Revenue by Region (2016-2026)
4.2 North America Chickenpox (Varicella) Vaccine Revenue (2016-2026)
4.3 Europe Chickenpox (Varicella) Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Chickenpox (Varicella) Vaccine Revenue (2016-2026)
4.5 South America Chickenpox (Varicella) Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Chickenpox (Varicella) Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Chickenpox (Varicella) Vaccine Revenue by Type (2016-2026)
5.3 Global Chickenpox (Varicella) Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Chickenpox (Varicella) Vaccine Revenue by Application (2016-2026)
6.3 Global Chickenpox (Varicella) Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chickenpox (Varicella) Vaccine Sales by Type (2016-2026)
7.2 North America Chickenpox (Varicella) Vaccine Sales by Application (2016-2026)
7.3 North America Chickenpox (Varicella) Vaccine Market Size by Country
7.3.1 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Chickenpox (Varicella) Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chickenpox (Varicella) Vaccine Sales by Type (2016-2026)
8.2 Europe Chickenpox (Varicella) Vaccine Sales by Application (2016-2026)
8.3 Europe Chickenpox (Varicella) Vaccine Market Size by Country
8.3.1 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Chickenpox (Varicella) Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size by Region
9.3.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chickenpox (Varicella) Vaccine Sales by Type (2016-2026)
10.2 South America Chickenpox (Varicella) Vaccine Sales by Application (2016-2026)
10.3 South America Chickenpox (Varicella) Vaccine Market Size by Country
10.3.1 South America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Chickenpox (Varicella) Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Chickenpox (Varicella) Vaccine Market Size by Country
11.3.1 Middle East & Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chickenpox (Varicella) Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chickenpox (Varicella) Vaccine Typical Distributors
12.3 Chickenpox (Varicella) Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Chickenpox (Varicella) Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chickenpox (Varicella) Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Chickenpox (Varicella) Vaccine Product and Services
Table 6. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Major Business
Table 9. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product and Services
Table 10. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Chickenpox (Varicella) Vaccine Product and Services
Table 14. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Shanghai Institute Basic Information, Manufacturing Base and Competitors
Table 16. Shanghai Institute Major Business
Table 17. Shanghai Institute Chickenpox (Varicella) Vaccine Product and Services
Table 18. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. BCHT Basic Information, Manufacturing Base and Competitors
Table 20. BCHT Major Business
Table 21. BCHT Chickenpox (Varicella) Vaccine Product and Services
Table 22. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Changsheng Basic Information, Manufacturing Base and Competitors
Table 24. Changsheng Major Business
Table 25. Changsheng Chickenpox (Varicella) Vaccine Product and Services
Table 26. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Keygen Basic Information, Manufacturing Base and Competitors
Table 28. Keygen Major Business
Table 29. Keygen Chickenpox (Varicella) Vaccine Product and Services
Table 30. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Green Cross Basic Information, Manufacturing Base and Competitors
Table 32. Green Cross Major Business
Table 33. Green Cross Chickenpox (Varicella) Vaccine Product and Services
Table 34. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biken Basic Information, Manufacturing Base and Competitors
Table 36. Biken Major Business
Table 37. Biken Chickenpox (Varicella) Vaccine Product and Services
Table 38. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Chickenpox (Varicella) Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 40. Global Chickenpox (Varicella) Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Chickenpox (Varicella) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Chickenpox (Varicella) Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 43. Head Office and Chickenpox (Varicella) Vaccine Production Site of Key Manufacturer
Table 44. Chickenpox (Varicella) Vaccine New Entrant and Capacity Expansion Plans
Table 45. Chickenpox (Varicella) Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Chickenpox (Varicella) Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 47. Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (K Doses)
Table 48. Global Chickenpox (Varicella) Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Chickenpox (Varicella) Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Chickenpox (Varicella) Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 51. Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (K Doses)
Table 52. Global Chickenpox (Varicella) Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Chickenpox (Varicella) Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Chickenpox (Varicella) Vaccine Price by Type (2016-2021e) & (USD/dose)
Table 55. Global Chickenpox (Varicella) Vaccine Price by Type (2021-2026) & (USD/dose)
Table 56. Global Chickenpox (Varicella) Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 57. Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (K Doses)
Table 58. Global Chickenpox (Varicella) Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Chickenpox (Varicella) Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Chickenpox (Varicella) Vaccine Price by Application (2016-2021e) & (USD/dose)
Table 61. Global Chickenpox (Varicella) Vaccine Price by Application (2021-2026) & (USD/dose)
Table 62. North America Chickenpox (Varicella) Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 63. North America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (K Doses)
Table 64. North America Chickenpox (Varicella) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Chickenpox (Varicella) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Chickenpox (Varicella) Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 67. North America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (K Doses)
Table 68. North America Chickenpox (Varicella) Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 69. North America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (K Doses)
Table 70. Europe Chickenpox (Varicella) Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 71. Europe Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (K Doses)
Table 72. Europe Chickenpox (Varicella) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Chickenpox (Varicella) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Chickenpox (Varicella) Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 75. Europe Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (K Doses)
Table 76. Europe Chickenpox (Varicella) Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 77. Europe Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (K Doses)
Table 78. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 79. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (K Doses)
Table 80. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 83. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (K Doses)
Table 84. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 85. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (K Doses)
Table 86. South America Chickenpox (Varicella) Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 87. South America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (K Doses)
Table 88. South America Chickenpox (Varicella) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Chickenpox (Varicella) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Chickenpox (Varicella) Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 91. South America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (K Doses)
Table 92. South America Chickenpox (Varicella) Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 93. South America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (K Doses)
Table 94. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 95. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (K Doses)
Table 96. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 99. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (K Doses)
Table 100. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 101. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (K Doses)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Chickenpox (Varicella) Vaccine Typical Distributors
Table 105. Chickenpox (Varicella) Vaccine Typical Customers
List of Figures
Figure 1. Chickenpox (Varicella) Vaccine Picture
Figure 2. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2020
Figure 3. Monovalent Vaccine
Figure 4. Combination Vaccine
Figure 5. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2020
Figure 6. Kids Injection
Figure 7. Adults Injection
Figure 8. Global Chickenpox (Varicella) Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Chickenpox (Varicella) Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Chickenpox (Varicella) Vaccine Sales (2016-2026) & (K Doses)
Figure 11. Global Chickenpox (Varicella) Vaccine Price by Type (2016-2026) & (USD/dose)
Figure 12. Global Chickenpox (Varicella) Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 13. Global Chickenpox (Varicella) Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Chickenpox (Varicella) Vaccine Market Drivers
Figure 15. Chickenpox (Varicella) Vaccine Market Restraints
Figure 16. Chickenpox (Varicella) Vaccine Market Trends
Figure 17. Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturer in 2020
Figure 18. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Manufacturer in 2020
Figure 19. Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Chickenpox (Varicella) Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Chickenpox (Varicella) Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2016-2026)
Figure 23. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2016-2026)
Figure 24. North America Chickenpox (Varicella) Vaccine Revenue (2016-2026) & (USD Million)
Figure 25. Europe Chickenpox (Varicella) Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. South America Chickenpox (Varicella) Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2016-2026)
Figure 30. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2016-2026)
Figure 31. Global Chickenpox (Varicella) Vaccine Price by Type (2016-2026) & (USD/dose)
Figure 32. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2016-2026)
Figure 33. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2016-2026)
Figure 34. Global Chickenpox (Varicella) Vaccine Price by Application (2016-2026) & (USD/dose)
Figure 35. North America Chickenpox (Varicella) Vaccine Sales Market Share by Type (2016-2026)
Figure 36. North America Chickenpox (Varicella) Vaccine Sales Market Share by Application (2016-2026)
Figure 37. North America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2016-2026)
Figure 38. North America Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2016-2026)
Figure 39. United States Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Type (2016-2026)
Figure 43. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Application (2016-2026)
Figure 44. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Country (2016-2026)
Figure 45. Europe Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2016-2026)
Figure 46. Germany Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2016-2026)
Figure 55. China Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Chickenpox (Varicella) Vaccine Sales Market Share by Type (2016-2026)
Figure 62. South America Chickenpox (Varicella) Vaccine Sales Market Share by Application (2016-2026)
Figure 63. South America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2016-2026)
Figure 64. South America Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source